Close
Back to KZR Stock Lookup

(KZR) – Momentum Movers

Jun 27, 2022 04:11 PM Kezar Life Sciences (KZR) Climbs 35% Following Positive Results from Phase 2 Trial Evaluating Zetomipzomib for Treatment of Patients with LN
Nov 15, 2021 04:48 PM Kezar Life Sciences (KZR) Climbs 47% Following Interim Results from the MISSION Phase 2 Trial
Jun 3, 2020 05:36 PM

Back to KZR Stock Lookup